Abbott opens new facility for sensors, CGMs
By HME News Staff
Updated 10:18 AM CST, Mon November 18, 2024
ABBOTT PARK, Ill. – Abbott on Nov. 18 held a ceremony to celebrate the official opening of a state-of-the-art manufacturing facility in Kilkenny, Ireland, part of its €440 million investment in the country. The new 30,000-square-meter Kilkenny facility is producing FreeStyle Libre 3 sensors and the latest generation in Abbott’s continuous glucose monitoring portfolio for people living with diabetes. "This is our latest commitment to providing innovative care and supporting people with diabetes to live healthier lives," said Robert Ford, chairman and CEO, Abbott. "The state-of-the-art Kilkenny facility will have the highest production of Libre sensors in the world to help meet the growing global demand for our world-leading FreeStyle Libre portfolio." Abbott’s Kilkenny facility is fully electric, powered by six air-to-water heat pumps, and has nearly 600 solar panels on the roof. It also features tanks for collecting rainwater to use onsite. Outside Ireland, Abbott is expanding its manufacturing capacity across Europe with a further £85 million investment in its Witney facility in Oxfordshire, U.K.
Comments